Global Risedronate Market Insights, Forecast to 2028

  • Report ID:236894
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Jun-22
  • No. of Pages: 108
                              
Risedronate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Risedronate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type 5 mg Tablets 35 mg Tablets 75 mg Tablets 150 mg Tablets Segment by Application Postmenopausal Osteoporosis Men with Osteoporosis By Company Merck Amgen Teva Mylan Apotex Sanofi Abbott Novartis Tecoland Taj Pharmaceuticals By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E
                        
1 Study Coverage 1.1 Risedronate Product Introduction 1.2 Market by Type 1.2.1 Global Risedronate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 5 mg Tablets 1.2.3 35 mg Tablets 1.2.4 75 mg Tablets 1.2.5 150 mg Tablets 1.3 Market by Application 1.3.1 Global Risedronate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Postmenopausal Osteoporosis 1.3.3 Men with Osteoporosis 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Risedronate Sales Estimates and Forecasts 2017-2028 2.2 Global Risedronate Revenue Estimates and Forecasts 2017-2028 2.3 Global Risedronate Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Risedronate Sales by Region 2.4.1 Global Risedronate Sales by Region (2017-2022) 2.4.2 Global Sales Risedronate by Region (2023-2028) 2.5 Global Risedronate Revenue by Region 2.5.1 Global Risedronate Revenue by Region (2017-2022) 2.5.2 Global Risedronate Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Risedronate Sales by Manufacturers 3.1.1 Global Top Risedronate Manufacturers by Sales (2017-2022) 3.1.2 Global Risedronate Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risedronate in 2021 3.2 Global Risedronate Revenue by Manufacturers 3.2.1 Global Risedronate Revenue by Manufacturers (2017-2022) 3.2.2 Global Risedronate Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Risedronate Revenue in 2021 3.3 Global Risedronate Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Risedronate Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Risedronate Sales by Type 4.1.1 Global Risedronate Historical Sales by Type (2017-2022) 4.1.2 Global Risedronate Forecasted Sales by Type (2023-2028) 4.1.3 Global Risedronate Sales Market Share by Type (2017-2028) 4.2 Global Risedronate Revenue by Type 4.2.1 Global Risedronate Historical Revenue by Type (2017-2022) 4.2.2 Global Risedronate Forecasted Revenue by Type (2023-2028) 4.2.3 Global Risedronate Revenue Market Share by Type (2017-2028) 4.3 Global Risedronate Price by Type 4.3.1 Global Risedronate Price by Type (2017-2022) 4.3.2 Global Risedronate Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Risedronate Sales by Application 5.1.1 Global Risedronate Historical Sales by Application (2017-2022) 5.1.2 Global Risedronate Forecasted Sales by Application (2023-2028) 5.1.3 Global Risedronate Sales Market Share by Application (2017-2028) 5.2 Global Risedronate Revenue by Application 5.2.1 Global Risedronate Historical Revenue by Application (2017-2022) 5.2.2 Global Risedronate Forecasted Revenue by Application (2023-2028) 5.2.3 Global Risedronate Revenue Market Share by Application (2017-2028) 5.3 Global Risedronate Price by Application 5.3.1 Global Risedronate Price by Application (2017-2022) 5.3.2 Global Risedronate Price Forecast by Application (2023-2028) 6 North America 6.1 North America Risedronate Market Size by Type 6.1.1 North America Risedronate Sales by Type (2017-2028) 6.1.2 North America Risedronate Revenue by Type (2017-2028) 6.2 North America Risedronate Market Size by Application 6.2.1 North America Risedronate Sales by Application (2017-2028) 6.2.2 North America Risedronate Revenue by Application (2017-2028) 6.3 North America Risedronate Market Size by Country 6.3.1 North America Risedronate Sales by Country (2017-2028) 6.3.2 North America Risedronate Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Risedronate Market Size by Type 7.1.1 Europe Risedronate Sales by Type (2017-2028) 7.1.2 Europe Risedronate Revenue by Type (2017-2028) 7.2 Europe Risedronate Market Size by Application 7.2.1 Europe Risedronate Sales by Application (2017-2028) 7.2.2 Europe Risedronate Revenue by Application (2017-2028) 7.3 Europe Risedronate Market Size by Country 7.3.1 Europe Risedronate Sales by Country (2017-2028) 7.3.2 Europe Risedronate Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Risedronate Market Size by Type 8.1.1 Asia Pacific Risedronate Sales by Type (2017-2028) 8.1.2 Asia Pacific Risedronate Revenue by Type (2017-2028) 8.2 Asia Pacific Risedronate Market Size by Application 8.2.1 Asia Pacific Risedronate Sales by Application (2017-2028) 8.2.2 Asia Pacific Risedronate Revenue by Application (2017-2028) 8.3 Asia Pacific Risedronate Market Size by Region 8.3.1 Asia Pacific Risedronate Sales by Region (2017-2028) 8.3.2 Asia Pacific Risedronate Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Risedronate Market Size by Type 9.1.1 Latin America Risedronate Sales by Type (2017-2028) 9.1.2 Latin America Risedronate Revenue by Type (2017-2028) 9.2 Latin America Risedronate Market Size by Application 9.2.1 Latin America Risedronate Sales by Application (2017-2028) 9.2.2 Latin America Risedronate Revenue by Application (2017-2028) 9.3 Latin America Risedronate Market Size by Country 9.3.1 Latin America Risedronate Sales by Country (2017-2028) 9.3.2 Latin America Risedronate Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Risedronate Market Size by Type 10.1.1 Middle East and Africa Risedronate Sales by Type (2017-2028) 10.1.2 Middle East and Africa Risedronate Revenue by Type (2017-2028) 10.2 Middle East and Africa Risedronate Market Size by Application 10.2.1 Middle East and Africa Risedronate Sales by Application (2017-2028) 10.2.2 Middle East and Africa Risedronate Revenue by Application (2017-2028) 10.3 Middle East and Africa Risedronate Market Size by Country 10.3.1 Middle East and Africa Risedronate Sales by Country (2017-2028) 10.3.2 Middle East and Africa Risedronate Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Merck 11.1.1 Merck Corporation Information 11.1.2 Merck Overview 11.1.3 Merck Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Merck Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Merck Recent Developments 11.2 Amgen 11.2.1 Amgen Corporation Information 11.2.2 Amgen Overview 11.2.3 Amgen Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Amgen Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Amgen Recent Developments 11.3 Teva 11.3.1 Teva Corporation Information 11.3.2 Teva Overview 11.3.3 Teva Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Teva Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Teva Recent Developments 11.4 Mylan 11.4.1 Mylan Corporation Information 11.4.2 Mylan Overview 11.4.3 Mylan Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Mylan Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Mylan Recent Developments 11.5 Apotex 11.5.1 Apotex Corporation Information 11.5.2 Apotex Overview 11.5.3 Apotex Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Apotex Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Apotex Recent Developments 11.6 Sanofi 11.6.1 Sanofi Corporation Information 11.6.2 Sanofi Overview 11.6.3 Sanofi Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Sanofi Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Sanofi Recent Developments 11.7 Abbott 11.7.1 Abbott Corporation Information 11.7.2 Abbott Overview 11.7.3 Abbott Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Abbott Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Abbott Recent Developments 11.8 Novartis 11.8.1 Novartis Corporation Information 11.8.2 Novartis Overview 11.8.3 Novartis Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Novartis Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Novartis Recent Developments 11.9 Tecoland 11.9.1 Tecoland Corporation Information 11.9.2 Tecoland Overview 11.9.3 Tecoland Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Tecoland Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Tecoland Recent Developments 11.10 Taj Pharmaceuticals 11.10.1 Taj Pharmaceuticals Corporation Information 11.10.2 Taj Pharmaceuticals Overview 11.10.3 Taj Pharmaceuticals Risedronate Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Taj Pharmaceuticals Risedronate Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Taj Pharmaceuticals Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Risedronate Industry Chain Analysis 12.2 Risedronate Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Risedronate Production Mode & Process 12.4 Risedronate Sales and Marketing 12.4.1 Risedronate Sales Channels 12.4.2 Risedronate Distributors 12.5 Risedronate Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Risedronate Industry Trends 13.2 Risedronate Market Drivers 13.3 Risedronate Market Challenges 13.4 Risedronate Market Restraints 14 Key Findings in The Global Risedronate Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
                
List of Tables Table 1. Global Risedronate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of 5 mg Tablets Table 3. Major Manufacturers of 35 mg Tablets Table 4. Major Manufacturers of 75 mg Tablets Table 5. Major Manufacturers of 150 mg Tablets Table 6. Global Risedronate Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Risedronate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Risedronate Sales by Region (2017-2022) & (MT) Table 9. Global Risedronate Sales Market Share by Region (2017-2022) Table 10. Global Risedronate Sales by Region (2023-2028) & (MT) Table 11. Global Risedronate Sales Market Share by Region (2023-2028) Table 12. Global Risedronate Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Risedronate Revenue Market Share by Region (2017-2022) Table 14. Global Risedronate Revenue by Region (2023-2028) & (US$ Million) Table 15. Global Risedronate Revenue Market Share by Region (2023-2028) Table 16. Global Risedronate Sales by Manufacturers (2017-2022) & (MT) Table 17. Global Risedronate Sales Share by Manufacturers (2017-2022) Table 18. Global Risedronate Revenue by Manufacturers (2017-2022) & (US$ Million) Table 19. Global Risedronate Revenue Share by Manufacturers (2017-2022) Table 20. Risedronate Price by Manufacturers (2017-2022) &(USD/Kg) Table 21. Global Risedronate Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Risedronate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risedronate as of 2021) Table 23. Risedronate Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Risedronate Product Offered Table 25. Date of Manufacturers Enter into Risedronate Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Risedronate Sales by Type (2017-2022) & (MT) Table 28. Global Risedronate Sales by Type (2023-2028) & (MT) Table 29. Global Risedronate Sales Share by Type (2017-2022) Table 30. Global Risedronate Sales Share by Type (2023-2028) Table 31. Global Risedronate Revenue by Type (2017-2022) & (US$ Million) Table 32. Global Risedronate Revenue by Type (2023-2028) & (US$ Million) Table 33. Global Risedronate Revenue Share by Type (2017-2022) Table 34. Global Risedronate Revenue Share by Type (2023-2028) Table 35. Risedronate Price by Type (2017-2022) & (USD/Kg) Table 36. Global Risedronate Price Forecast by Type (2023-2028) & (USD/Kg) Table 37. Global Risedronate Sales by Application (2017-2022) & (MT) Table 38. Global Risedronate Sales by Application (2023-2028) & (MT) Table 39. Global Risedronate Sales Share by Application (2017-2022) Table 40. Global Risedronate Sales Share by Application (2023-2028) Table 41. Global Risedronate Revenue by Application (2017-2022) & (US$ Million) Table 42. Global Risedronate Revenue by Application (2023-2028) & (US$ Million) Table 43. Global Risedronate Revenue Share by Application (2017-2022) Table 44. Global Risedronate Revenue Share by Application (2023-2028) Table 45. Risedronate Price by Application (2017-2022) & (USD/Kg) Table 46. Global Risedronate Price Forecast by Application (2023-2028) & (USD/Kg) Table 47. North America Risedronate Sales by Type (2017-2022) & (MT) Table 48. North America Risedronate Sales by Type (2023-2028) & (MT) Table 49. North America Risedronate Revenue by Type (2017-2022) & (US$ Million) Table 50. North America Risedronate Revenue by Type (2023-2028) & (US$ Million) Table 51. North America Risedronate Sales by Application (2017-2022) & (MT) Table 52. North America Risedronate Sales by Application (2023-2028) & (MT) Table 53. North America Risedronate Revenue by Application (2017-2022) & (US$ Million) Table 54. North America Risedronate Revenue by Application (2023-2028) & (US$ Million) Table 55. North America Risedronate Sales by Country (2017-2022) & (MT) Table 56. North America Risedronate Sales by Country (2023-2028) & (MT) Table 57. North America Risedronate Revenue by Country (2017-2022) & (US$ Million) Table 58. North America Risedronate Revenue by Country (2023-2028) & (US$ Million) Table 59. Europe Risedronate Sales by Type (2017-2022) & (MT) Table 60. Europe Risedronate Sales by Type (2023-2028) & (MT) Table 61. Europe Risedronate Revenue by Type (2017-2022) & (US$ Million) Table 62. Europe Risedronate Revenue by Type (2023-2028) & (US$ Million) Table 63. Europe Risedronate Sales by Application (2017-2022) & (MT) Table 64. Europe Risedronate Sales by Application (2023-2028) & (MT) Table 65. Europe Risedronate Revenue by Application (2017-2022) & (US$ Million) Table 66. Europe Risedronate Revenue by Application (2023-2028) & (US$ Million) Table 67. Europe Risedronate Sales by Country (2017-2022) & (MT) Table 68. Europe Risedronate Sales by Country (2023-2028) & (MT) Table 69. Europe Risedronate Revenue by Country (2017-2022) & (US$ Million) Table 70. Europe Risedronate Revenue by Country (2023-2028) & (US$ Million) Table 71. Asia Pacific Risedronate Sales by Type (2017-2022) & (MT) Table 72. Asia Pacific Risedronate Sales by Type (2023-2028) & (MT) Table 73. Asia Pacific Risedronate Revenue by Type (2017-2022) & (US$ Million) Table 74. Asia Pacific Risedronate Revenue by Type (2023-2028) & (US$ Million) Table 75. Asia Pacific Risedronate Sales by Application (2017-2022) & (MT) Table 76. Asia Pacific Risedronate Sales by Application (2023-2028) & (MT) Table 77. Asia Pacific Risedronate Revenue by Application (2017-2022) & (US$ Million) Table 78. Asia Pacific Risedronate Revenue by Application (2023-2028) & (US$ Million) Table 79. Asia Pacific Risedronate Sales by Region (2017-2022) & (MT) Table 80. Asia Pacific Risedronate Sales by Region (2023-2028) & (MT) Table 81. Asia Pacific Risedronate Revenue by Region (2017-2022) & (US$ Million) Table 82. Asia Pacific Risedronate Revenue by Region (2023-2028) & (US$ Million) Table 83. Latin America Risedronate Sales by Type (2017-2022) & (MT) Table 84. Latin America Risedronate Sales by Type (2023-2028) & (MT) Table 85. Latin America Risedronate Revenue by Type (2017-2022) & (US$ Million) Table 86. Latin America Risedronate Revenue by Type (2023-2028) & (US$ Million) Table 87. Latin America Risedronate Sales by Application (2017-2022) & (MT) Table 88. Latin America Risedronate Sales by Application (2023-2028) & (MT) Table 89. Latin America Risedronate Revenue by Application (2017-2022) & (US$ Million) Table 90. Latin America Risedronate Revenue by Application (2023-2028) & (US$ Million) Table 91. Latin America Risedronate Sales by Country (2017-2022) & (MT) Table 92. Latin America Risedronate Sales by Country (2023-2028) & (MT) Table 93. Latin America Risedronate Revenue by Country (2017-2022) & (US$ Million) Table 94. Latin America Risedronate Revenue by Country (2023-2028) & (US$ Million) Table 95. Middle East and Africa Risedronate Sales by Type (2017-2022) & (MT) Table 96. Middle East and Africa Risedronate Sales by Type (2023-2028) & (MT) Table 97. Middle East and Africa Risedronate Revenue by Type (2017-2022) & (US$ Million) Table 98. Middle East and Africa Risedronate Revenue by Type (2023-2028) & (US$ Million) Table 99. Middle East and Africa Risedronate Sales by Application (2017-2022) & (MT) Table 100. Middle East and Africa Risedronate Sales by Application (2023-2028) & (MT) Table 101. Middle East and Africa Risedronate Revenue by Application (2017-2022) & (US$ Million) Table 102. Middle East and Africa Risedronate Revenue by Application (2023-2028) & (US$ Million) Table 103. Middle East and Africa Risedronate Sales by Country (2017-2022) & (MT) Table 104. Middle East and Africa Risedronate Sales by Country (2023-2028) & (MT) Table 105. Middle East and Africa Risedronate Revenue by Country (2017-2022) & (US$ Million) Table 106. Middle East and Africa Risedronate Revenue by Country (2023-2028) & (US$ Million) Table 107. Merck Corporation Information Table 108. Merck Description and Major Businesses Table 109. Merck Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 110. Merck Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 111. Merck Recent Developments Table 112. Amgen Corporation Information Table 113. Amgen Description and Major Businesses Table 114. Amgen Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 115. Amgen Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Amgen Recent Developments Table 117. Teva Corporation Information Table 118. Teva Description and Major Businesses Table 119. Teva Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 120. Teva Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Teva Recent Developments Table 122. Mylan Corporation Information Table 123. Mylan Description and Major Businesses Table 124. Mylan Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 125. Mylan Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 126. Mylan Recent Developments Table 127. Apotex Corporation Information Table 128. Apotex Description and Major Businesses Table 129. Apotex Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 130. Apotex Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 131. Apotex Recent Developments Table 132. Sanofi Corporation Information Table 133. Sanofi Description and Major Businesses Table 134. Sanofi Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 135. Sanofi Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 136. Sanofi Recent Developments Table 137. Abbott Corporation Information Table 138. Abbott Description and Major Businesses Table 139. Abbott Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 140. Abbott Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 141. Abbott Recent Developments Table 142. Novartis Corporation Information Table 143. Novartis Description and Major Businesses Table 144. Novartis Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 145. Novartis Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 146. Novartis Recent Developments Table 147. Tecoland Corporation Information Table 148. Tecoland Description and Major Businesses Table 149. Tecoland Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 150. Tecoland Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 151. Tecoland Recent Developments Table 152. Taj Pharmaceuticals Corporation Information Table 153. Taj Pharmaceuticals Description and Major Businesses Table 154. Taj Pharmaceuticals Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 155. Taj Pharmaceuticals Risedronate Product Model Numbers, Pictures, Descriptions and Specifications Table 156. Taj Pharmaceuticals Recent Developments Table 157. Key Raw Materials Lists Table 158. Raw Materials Key Suppliers Lists Table 159. Risedronate Distributors List Table 160. Risedronate Customers List Table 161. Risedronate Market Trends Table 162. Risedronate Market Drivers Table 163. Risedronate Market Challenges Table 164. Risedronate Market Restraints Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Risedronate Product Picture Figure 3. Global Risedronate Market Share by Type in 2021 & 2028 Figure 3. 5 mg Tablets Product Picture Figure 4. 35 mg Tablets Product Picture Figure 5. 75 mg Tablets Product Picture Figure 6. 150 mg Tablets Product Picture Figure 7. Global Risedronate Market Share by Application in 2021 & 2028 Figure 8. Postmenopausal Osteoporosis Figure 9. Men with Osteoporosis Figure 10. Risedronate Report Years Considered Figure 11. Global Risedronate Sales 2017-2028 (MT) Figure 12. Global Risedronate Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Risedronate Revenue 2017-2028 (US$ Million) Figure 14. Global Risedronate Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 15. Global Risedronate Sales Market Share by Region (2017-2022) Figure 16. Global Risedronate Sales Market Share by Region (2023-2028) Figure 17. North America Risedronate Sales YoY (2017-2028) & (MT) Figure 18. North America Risedronate Revenue YoY (2017-2028) & (US$ Million) Figure 19. Europe Risedronate Sales YoY (2017-2028) & (MT) Figure 20. Europe Risedronate Revenue YoY (2017-2028) & (US$ Million) Figure 21. Asia-Pacific Risedronate Sales YoY (2017-2028) & (MT) Figure 22. Asia-Pacific Risedronate Revenue YoY (2017-2028) & (US$ Million) Figure 23. Latin America Risedronate Sales YoY (2017-2028) & (MT) Figure 24. Latin America Risedronate Revenue YoY (2017-2028) & (US$ Million) Figure 25. Middle East & Africa Risedronate Sales YoY (2017-2028) & (MT) Figure 26. Middle East & Africa Risedronate Revenue YoY (2017-2028) & (US$ Million) Figure 27. The Risedronate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 28. The Top 5 and 10 Largest Manufacturers of Risedronate in the World: Market Share by Risedronate Revenue in 2021 Figure 29. Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 30. Global Risedronate Sales Market Share by Type (2017-2028) Figure 31. Global Risedronate Revenue Market Share by Type (2017-2028) Figure 32. Global Risedronate Sales Market Share by Application (2017-2028) Figure 33. Global Risedronate Revenue Market Share by Application (2017-2028) Figure 34. North America Risedronate Sales Market Share by Type (2017-2028) Figure 35. North America Risedronate Revenue Market Share by Type (2017-2028) Figure 36. North America Risedronate Sales Market Share by Application (2017-2028) Figure 37. North America Risedronate Revenue Market Share by Application (2017-2028) Figure 38. North America Risedronate Sales Share by Country (2017-2028) Figure 39. North America Risedronate Revenue Share by Country (2017-2028) Figure 40. U.S. Risedronate Revenue (2017-2028) & (US$ Million) Figure 41. Canada Risedronate Revenue (2017-2028) & (US$ Million) Figure 42. Europe Risedronate Sales Market Share by Type (2017-2028) Figure 43. Europe Risedronate Revenue Market Share by Type (2017-2028) Figure 44. Europe Risedronate Sales Market Share by Application (2017-2028) Figure 45. Europe Risedronate Revenue Market Share by Application (2017-2028) Figure 46. Europe Risedronate Sales Share by Country (2017-2028) Figure 47. Europe Risedronate Revenue Share by Country (2017-2028) Figure 48. Germany Risedronate Revenue (2017-2028) & (US$ Million) Figure 49. France Risedronate Revenue (2017-2028) & (US$ Million) Figure 50. U.K. Risedronate Revenue (2017-2028) & (US$ Million) Figure 51. Italy Risedronate Revenue (2017-2028) & (US$ Million) Figure 52. Russia Risedronate Revenue (2017-2028) & (US$ Million) Figure 53. Asia Pacific Risedronate Sales Market Share by Type (2017-2028) Figure 54. Asia Pacific Risedronate Revenue Market Share by Type (2017-2028) Figure 55. Asia Pacific Risedronate Sales Market Share by Application (2017-2028) Figure 56. Asia Pacific Risedronate Revenue Market Share by Application (2017-2028) Figure 57. Asia Pacific Risedronate Sales Share by Region (2017-2028) Figure 58. Asia Pacific Risedronate Revenue Share by Region (2017-2028) Figure 59. China Risedronate Revenue (2017-2028) & (US$ Million) Figure 60. Japan Risedronate Revenue (2017-2028) & (US$ Million) Figure 61. South Korea Risedronate Revenue (2017-2028) & (US$ Million) Figure 62. India Risedronate Revenue (2017-2028) & (US$ Million) Figure 63. Australia Risedronate Revenue (2017-2028) & (US$ Million) Figure 64. Taiwan Risedronate Revenue (2017-2028) & (US$ Million) Figure 65. Indonesia Risedronate Revenue (2017-2028) & (US$ Million) Figure 66. Thailand Risedronate Revenue (2017-2028) & (US$ Million) Figure 67. Malaysia Risedronate Revenue (2017-2028) & (US$ Million) Figure 68. Philippines Risedronate Revenue (2017-2028) & (US$ Million) Figure 69. Latin America Risedronate Sales Market Share by Type (2017-2028) Figure 70. Latin America Risedronate Revenue Market Share by Type (2017-2028) Figure 71. Latin America Risedronate Sales Market Share by Application (2017-2028) Figure 72. Latin America Risedronate Revenue Market Share by Application (2017-2028) Figure 73. Latin America Risedronate Sales Share by Country (2017-2028) Figure 74. Latin America Risedronate Revenue Share by Country (2017-2028) Figure 75. Mexico Risedronate Revenue (2017-2028) & (US$ Million) Figure 76. Brazil Risedronate Revenue (2017-2028) & (US$ Million) Figure 77. Argentina Risedronate Revenue (2017-2028) & (US$ Million) Figure 78. Middle East and Africa Risedronate Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa Risedronate Revenue Market Share by Type (2017-2028) Figure 80. Middle East and Africa Risedronate Sales Market Share by Application (2017-2028) Figure 81. Middle East and Africa Risedronate Revenue Market Share by Application (2017-2028) Figure 82. Middle East and Africa Risedronate Sales Share by Country (2017-2028) Figure 83. Middle East and Africa Risedronate Revenue Share by Country (2017-2028) Figure 84. Turkey Risedronate Revenue (2017-2028) & (US$ Million) Figure 85. Saudi Arabia Risedronate Revenue (2017-2028) & (US$ Million) Figure 86. U.A.E Risedronate Revenue (2017-2028) & (US$ Million) Figure 87. Risedronate Value Chain Figure 88. Risedronate Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.